Among the differentially expressed microRNAs, miR‐133a, was discovered as a potential marker of disease severity and reaction to therapy (Tarallo et al gene that encodes the lysosomal Ca2+‐releasing channel TRPML1. Mucolipidosis IV pathology could be the consequence of defective TRPML1 function and aberrant Ca2+ signaling, and is characterized by impaired https://freemani023hea1.blogdun.com/profile